Clinical Trial

Botulinum Toxin Injection After Sternotomies to Improve Scar Aspect and Impact

Study acronym: BotuCiSter
Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Sternotomy scars, which are localized in a high-tension area are often dystrophic, hypertrophic or keloidal, and can be difficult to accept to patients who already endured a heavy intervention with high psychologic impact. The investigators wish to evaluate immediate post-surgical injection of botulinum toxin to improve scar aspect and impact. A randomized, placebo-controlled, split-scar clinical trial will determine the improvement of scar aspects assessed by standardized scores (SBSES, POSAS), patient satisfaction and tolerance.
Trial Details
NCT Number NCT07013240
Lead Sponsor University Hospital, Bordeaux
Conditions Sternotomy Closure,Open Heart Surgery
Enrollment 50 participants
Start Date 2025-07-05
Primary Completion 2027-02-28 (estimated)
Study Completion 2027-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-06-10